HuGE Literature Finder
|
||
Records 1-100
|
Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation.
Scientific reports 2019 Mar 9 (1): 3750. Ibrahim-Kosta M, Suchon P, Couturaud F, Smadja D, Olaso R, Germain M, Saut N, Goumidi L, Derbois C, Thibord F, Debette S, Amouyel P, Deleuze J F, van Doorn P, Castoldi E, Patin E, Alessi M C, Trégouët D A, Morange P |
|
CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.
Platelets 2019 30 (2): 229-240. Xi Ziwei, Fang Fang, Wang Jiayang, AlHelal Jumana, Zhou Yujie, Liu W |
|
Non-genetic and genetic risk factors for adult cerebral venous thrombosis.
Thrombosis research 2018 Jul 169 15-22. Green Mackenzie, Styles Toby, Russell Timothy, Sada Charif, Jallow Ebrima, Stewart Jack, Lazariashvili Otar, Lubomirova Irina, Cotlarciuc Ioana, Sharma Sapna, Han Thang S, Sharma Pank |
|
Impact of interleukin 6 promoter polymorphisms (-174 G?>?C, -572 G?>?C and -597 G?>?A) on plasma IL-6 levels and their influence on the development of DVT: a study from India.
Hematology (Amsterdam, Netherlands) 2018 Jun 1-6. Sharma Amit, Singh Kanwaljeet, Biswas Arijit, Ranjan Ravi, Kishor Kamal, Pandey Hareram, Kumar Ravi, Mahapatra Manoranjan, Oldenburg Johannes, Saxena Re |
|
Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population.
Journal of thrombosis and thrombolysis 2018 May . Kishor Kamal, Sharma Amit, Singh Kanwaljeet, Ranjan Ravi, Pandey Hareram, Kumar Ravi, Kamal Vineet Kumar, Mishra Pravas, Mahapatra Manoranjan, Saxena Re |
|
Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation.
Pediatric blood & cancer 2018 Jan . Athale Uma H, Mizrahi T, Laverdière C, Nayiager T, Delva Y-L, Foster G, Thabane L, David M, Leclerc J-M, Chan A K |
|
Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
PloS one 2018 13 (5): e0194973. Heraudeau Adeline, Delluc Aurélien, Le Henaff Mickaël, Lacut Karine, Leroyer Christophe, Desrues Benoit, Couturaud Francis, Tromeur Céci |
|
The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behçet's disease.
International journal of rheumatic diseases 2017 Aug . Cosan Fulya, Oku Basar, Gedar Totuk Ozgun M, Abaci Neslihan, Ustek Duran, Diz Kucukkaya Reyhan, Gul Ahm |
|
The Role of Protein Z and Protein Z-Dependent Protease Inhibitor Polymorphisms in the Development of Prosthetic Heart Valve Thrombosis.
The Journal of heart valve disease 2017 Jul 26 (4): 460-466. Karakoyun Süleyman, Ozan Gürsoy Mustafa, Kalç?k Macit, Yesin Mahmut, Gündüz Sabahattin, Ali Astarc?o?lu Mehmet, Bayram Zübeyde, Çakal Beytullah, Bayam Emrah, Özkan Mehm |
|
Intravenous immunoglobulin for treatment of severe refractory heparin-induced thrombocytopenia.
Chest 2017 Apr . Padmanabhan Anand, Jones Curtis G, Pechauer Shannon M, Curtis Brian R, Bougie Daniel W, Irani Mehraboon S, Bryant Barbara J, Alperin Jack B, Deloughery Thomas G, Mulvey Kevin P, Dhakal Binod, Wen Renren, Wang Demin, Aster Richard |
|
Prevalence of Factor V Leiden-G1691A and MTHFR-C677T Thrombosis Gene Modifier in Iron Deficiency Anemia: A Pathophysiological Effect in Indian Isolates.
Indian journal of clinical biochemistry : IJCB 2017 Mar 32 (1): 103-105. Pandey S K, Pandey S, Mishra R M, Indurkar |
|
Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocol.
BMJ open 2016 Nov 6 (11): e012351. Cotlarciuc Ioana, Marjot Thomas, Khan Muhammad S, Hiltunen Sini, Haapaniemi Elena, Metso Tiina M, Putaala Jukka, Zuurbier Susanna M, Brouwer Matthijs C, Passamonti Serena M, Bucciarelli Paolo, Pappalardo Emanuela, Patel Tasmin, Costa Paolo, Colombi Marina, Canhão Patrícia, Tkach Aleksander, Santacroce Rosa, Margaglione Maurizio, Favuzzi Giovanni, Grandone Elvira, Colaizzo Donatella, Spengos Kostas, Arauz Antonio, Hodge Amanda, Ditta Reina, Debette Stephanie, Zedde Marialuisa, Pare Guillaume, Ferro José M, Thijs Vincent, Pezzini Alessandro, Majersik Jennifer J, Martinelli Ida, Coutinho Jonathan M, Tatlisumak Turgut, Sharma Pankaj, |
|
Gene polymorphism of CYP2C19*2, *3 and CYP3A4*1B and early stent thrombosis: case reports and literature review.
Personalized medicine 2016 Sep 13 (5): 423-428. Kulmyrzaeva Nazgul, Tatarunas Vacis, Skipskis Vilius, Smagulova Gaziza, Seitmaganbetova Nazgul, Veikutiene Audrone, Lesauskaite Vai |
|
Genetic Risk Factors in Venous Thromboembolism.
Advances in experimental medicine and biology 2016 Sep . Hotoleanu Cristi |
|
The efficacy of tissue factor -603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients.
Experimental oncology 2016 Sep 38 (3): 187-90. Ero?lu A, Ceylan G G, Ozturk E, Yalcin A, Yalcin B, Karasoy |
|
The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome.
Yonsei medical journal 2016 Sep 57 (5): 1230-5. Aracic Nada, Roje Damir, Jakus Ivana Alujevic, Bakotin Marinela, Stefanovic Vedr |
|
Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study.
Clinical genetics 2016 Jul . Suchon Pierre, Frouh Fadi Al, Ibrahim Manal, Sarlon Gabrielle, Venton Geoffroy, Alessi Marie-Christine, Trégouët David-Alexandre, Morange Pierre-Emmanu |
|
CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents.
Medicine 2016 Jun 95 (26): e4049. Choi Ik Jun, Koh Yoon-Seok, Park Mahn-Won, Her Sung Ho, Choi Yun-Seok, Park Chul-Soo, Park Hun-Jun, Kim Pum-Joon, Chung Wook-Sung, Kim Ho-Sook, Shin Jae-Gook, Seung Ki-Bae, Chang Kiy |
|
Thrombotic risk correlates with mutational status in true-essential thrombocythemia.
European journal of clinical investigation 2016 Jun . Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi M |
|
[Hereditary thrombophilia testing and its therapeutic impact on venous thromboembolism disease: Results from a retrospective single-center study of 162 patients].
La Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne 2016 May . Allain J-S, Gueret P, Le Gallou T, Cazalets C, Lescoat A, Jego |
|
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.
American journal of hematology 2016 May 91 (5): 503-6. Elala Yoseph C, Lasho Terra L, Gangat Naseema, Finke Christy, Barraco Daniela, Haider Mahnur, Abou Hussein Ahmed K, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
|
Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.
Molecular biology reports 2016 Apr . Jarrar Mohammed, Behl Shalini, Manyam Ganiraju, Ganah Hany, Nazir Mohammed, Nasab Reem, Moustafa Khal |
|
Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis.
PloS one 2016 11 (11): e0165665. Pagliari Maria Teresa, Lotta Luca A, de Haan Hugoline G, Valsecchi Carla, Casoli Gloria, Pontiggia Silvia, Martinelli Ida, Passamonti Serena M, Rosendaal Frits R, Peyvandi Flo |
|
Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.
Gene 2015 Sep 569 (2): 173-81. Qian Kai, Xu Jie, Wan Heng, Fu Fangyong, Lu Jingbo, Lin Zhiqi, Liu Zhengjun, Liu H |
|
Pharmacogenomic Testing and Warfarin Management.
Oncology nursing forum 2015 Sep 42 (5): 563-5. Maluso Andr |
|
Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Aug . Moussaoui S, Saussoy P, Ambroise J, Defour J P, Zouitene R, Sifi K, Abadi |
|
A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.
The Indian journal of medical research 2015 Jul 142 (1): 46-52. Karimi Ali, Abolhasani Marziyeh, Hashemzadeh-Chaleshtori Morteza, Pourgheysari Bato |
|
JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.
Pathology oncology research : POR 2015 Jul 21 (3): 751-8. Pósfai Éva, Marton Imelda, Király Péter Attila, Kotosz Balázs, Kiss-László Zsuzsanna, Széll Márta, Borbényi Zi |
|
Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status.
European journal of haematology 2015 Jun . Mela Osorio María J, Ferrari Luciana, Goette Nora P, Gutierrez Marina I, Glembotsky Ana C, Maldonado Ana C, Lev Paola R, Alvarez Clarisa, Korin Laura, Marta Rosana F, Molinas Felisa C, Heller Paula |
|
The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2015 Jun 98 (6): 549-54. Sermsathanasawadi Nuttawut, Sritongsathian Chukij, Pongrattanaman Nunthapol, Praditsuktavorn Banjerd, Hongku Kiattisak, Wongwanit Chumpol, Ruangsetakit Chanean, Chinsakchai Khamin, Mutirangura Pramook, Poungvarin Narav |
|
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis.
Turkish journal of haematology : official journal of Turkish Society of Haematology 2015 Apr . Yönal Ipek, Da?lar Aday Aynur, Akadam Teker Ba?ak, Ceylan Y?lmaz, Nalcac? Meliha, Yavuz Akif Selim, Sarg?n Fatma Den |
|
Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Apr 26 (3): 309-15. Wahba Mona Ahmed, Ismail Mona Ahmed, Saad Abeer Attia, Habashy Deena Mohamed, Hafeez Zeinab Mohamed Abdel, Boshnak Noha Husse |
|
Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea.
Annals of laboratory medicine 2015 Mar 35 (2): 233-7. Park Sang Hyuk, Kim Shine Young, Lee Sun Min, Yi Jongyoun, Kim In-Suk, Kim Hyung Hoi, Chang Chulhun Ludgerus, Lee Eun Yup, Song Moo-Kon, Shin Ho-Jin, Chung Joo Se |
|
Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.
Hepatology (Baltimore, Md.) 2015 Feb 61 (2): 660-7. Nery Filipe, Chevret Sylvie, Condat Bertrand, de Raucourt Emmanuelle, Boudaoud Larbi, Rautou Pierre-Emmanuel, Plessier Aurelie, Roulot Dominique, Chaffaut Cendrine, Bourcier Valerie, Trinchet Jean-Claude, Valla Dominique-Charles, |
|
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
Journal of thrombosis and haemostasis : JTH 2015 Jan 13 (1): 17-22. Pabinger I, Ay C, Dunkler D, Thaler J, Reitter E-M, Marosi C, Zielinski C, Mannhalter |
|
Haemostaseome-associated SNPs: has the thrombotic phenotype a greater influence than ethnicity? GMT study from Aquitaine including Basque individuals.
Thrombosis and haemostasis 2015 Jan 113 (1): 66-76. Freyburger Geneviève, Labrouche Sylvie, Hubert Christophe, Bauduer Frédér |
|
Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
European journal of haematology 2015 Jan 94 (1): 31-6. Gangat Naseema, Wassie Emnet A, Lasho Terra L, Finke Christy, Ketterling Rhett P, Hanson Curtis A, Pardanani Animesh, Wolanskyj Alexandra P, Maffioli Margherita, Casalone Rosario, Passamonti Francesco, Tefferi Ayal |
|
Effect of clinical factors and gene polymorphism of CYP2C19*2, *17 and CYP4F2*3 on early stent thrombosis.
Pharmacogenomics 2015 16 (3): 181-9. Kupstyte Nora, Zaliunas Remigijus, Tatarunas Vacis, Skipskis Vilius, Zaliaduonyte-Peksiene Diana, Grabauskyte Ingrida, Dovidaitiene Dovile, Bumblauskas Karolis, Gustiene Olivija, Lesauskaite Vai |
|
Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population.
Thrombosis journal 2015 13 35. Hosseini Soudabeh, Kalantar Ebrahim, Hosseini Maryam Sadat, Tabibian Shadi, Shamsizadeh Morteza, Dorgalaleh Akb |
|
Calreticulin mutations and long-term survival in essential thrombocythemia.
Leukemia 2014 Dec 28 (12): 2300-3. Tefferi A, Wassie E A, Lasho T L, Finke C, Belachew A A, Ketterling R P, Hanson C A, Pardanani A, Gangat N, Wolanskyj A |
|
Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia.
Annals of hematology 2014 Dec 93 (12): 2029-36. Chen Chih-Cheng, Gau Jyh-Pyng, Chou Hui-Ju, You Jie-Yu, Huang Cih-En, Chen Yi-Yang, Lung Jrhau, Chou Yi-Sheng, Leu Yu-Wei, Lu Chang-Hsien, Lee Kuan-Der, Tsai Ying-Hua |
|
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2014 Sep 12 (9): 1480-7. Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci P |
|
Screening of the GPX3 gene identifies the "T" allele of the SNP -861A/T as a risk for ischemic stroke in young Asian Indians.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2014 Sep 23 (8): 2060-8. Akhter Mohammad S, Biswas Arijit, Rashid Hina, Devi Luxmi, Behari Madhuri, Saxena Re |
|
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood 2014 Aug 124 (7): 1062-9. Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario, |
|
Decanucleotide insertion polymorphism of F7 significantly influences the risk of thrombosis in patients with essential thrombocythemia.
European journal of haematology 2014 Aug 93 (2): 103-11. Buxhofer-Ausch Veronika, Olcaydu Damla, Gisslinger Bettina, Schalling Martin, Frantal Sophie, Thiele Jürgen, Müllauer Leonhard, Kvasnicka Hans-Michael, Watzke Herbert, Kralovics Robert, Gisslinger Hei |
|
Endothelial Protein C Receptor Gene Variants and Risk of Thrombosis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2014 Aug . Anastasiou Georgia, Politou Marianna, Rallidis Loukianos, Grouzi Elisavet, Karakitsos Petros, Merkouri Efrosini, Travlou Anthi, Gialeraki Argy |
|
[Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel].
Medicina clínica 2014 Jul 143 (1): 6-12. Cano Pedro, Consuegra-Sánchez Luciano, Conesa Pablo, Torres-Moreno Daniel, Jaulent Leticia, Dau Derek, Picó Francisco, Villegas Manu |
|
Impact of coagulation in the development of thromboembolic events in patients with spinal cord injury.
Spinal cord 2014 Apr 52 (4): 327-32. de Campos Guerra J C, Mourão M A, França C N, da Rosa C D P, Burattini M |
|
The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease.
Pharmacogenetics and genomics 2014 Apr 24 (4): 204-10. Xie Cheng, Ding Xiaoliang, Gao Jie, Wang Haipeng, Hang Yongfu, Zhang Hua, Zhang Jingjing, Jiang Bin, Miao Liy |
|
Association between thrombophilia and seated immobility venous thromboembolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2014 Mar 25 (2): 135-41. Siniarski Aleksander, Wypasek Ewa, Fijorek Kamil, Gajos Grzegorz, Undas Anet |
|
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.
Blood 2014 Mar 123 (10): 1552-5. Rotunno Giada, Mannarelli Carmela, Guglielmelli Paola, Pacilli Annalisa, Pancrazzi Alessandro, Pieri Lisa, Fanelli Tiziana, Bosi Alberto, Vannucchi Alessandro M, |
|
Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
Thrombosis and haemostasis 2014 Feb 111 (2): 249-57. Luxembourg Beate, Pavlova Anna, Geisen Christof, Spannagl Michael, Bergmann Frauke, Krause Manuela, Alesci Sonja, Seifried Erhard, Lindhoff-Last Edelga |
|
Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation.
Lipids in health and disease 2014 13 (1): 21. Zhu Shuangli, Wang ZhiGang, Wu XiaoPing, Shu Yan, Lu DunXia |
|
Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.
Archives of cardiovascular diseases 2013 Oct 106 (10): 517-27. Mao Liu, Jian Chen, Changzhi Liu, Dan Huang, Suihua Huang, Wenyi Tang, Wei |
|
Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention.
Pharmacogenetics and genomics 2013 Oct 23 (10): 558-62. Park Mahn-Won, Her Sung Ho, Kim Ho-Sook, Choi Yun-Seok, Park Chul-Soo, Koh Yoon-Seok, Park Hun-Jun, Kim Pum-Joon, Kim Chan Joon, Jeon Doo Soo, Shin Dong Il, Seo Suk Min, Yoo Ki-Dong, Kim Dong Bin, Kim Hee Yeol, Lee Jong Min, Chung Wook-Sung, Seung Ki-Bae, Shin Jae-Gook, Chang Kiy |
|
Promoter variants of VTN are associated with vascular disease.
International journal of cardiology 2013 Sep 168 (1): 163-8. Wang Yibo, Xu Jing, Chen Jinxing, Fan Xiaohan, Zhang Yu, Yu Weifeng, Liu Jibin, Hui Rut |
|
Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.
Thrombosis research 2013 Aug 132 (2): e99-e104. Colaizzo Donatella, Amitrano Lucio, Guardascione Maria Anna, Tiscia Giovanni Luca, D'Andrea Giovanna, Longo Vittoria A C, Grandone Elvira, Margaglione Mauriz |
|
The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013 Jul 9 (3): 316-27. Liang Zhen-Yang, Han Ya-Ling, Zhang Xiao-Lin, Li Yi, Yan Cheng-Hui, Kang Ji |
|
Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention.
European journal of clinical pharmacology 2013 Apr 69 (4): 771-7. Zou Jian-Jun, Xie Hong-Guang, Chen Shao-Liang, Tan Jie, Lin Ling, Zhao Ying-Ying, Xu Hai-Mei, Lin Song, Zhang Juan, Wang Guang- |
Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.
Proceedings of the National Academy of Sciences of the United States of America 2013 Jan 110 (2): 588-93. Desch Karl C, Ozel Ayse B, Siemieniak David, Kalish Yossi, Shavit Jordan A, Thornburg Courtney D, Sharathkumar Anjali A, McHugh Caitlin P, Laurie Cathy C, Crenshaw Andrew, Mirel Daniel B, Kim Yoonhee, Cropp Cheryl D, Molloy Anne M, Kirke Peadar N, Bailey-Wilson Joan E, Wilson Alexander F, Mills James L, Scott John M, Brody Lawrence C, Li Jun Z, Ginsburg Dav |
|
Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
|
The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.
Thrombosis research 2012 Sep 130 (3): 441-4. Ahmad-Nejad Parviz, Dempfle Carl-Erik, Weiss Christel, Bugert Peter, Borggrefe Martin, Neumaier Micha |
|
Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel.
The American journal of cardiology 2012 Aug 110 (4): 502-8. Jang Jae-Sik, Cho Kyoung-Im, Jin Han-Young, Seo Jeong-Sook, Yang Tae-Hyun, Kim Dae-Kyeong, Kim Dong-Soo, Seol Sang-Hoon, Kim Doo-Il, Kim Bo-Hyun, Park Yong Hyun, Je Hyung-Gon, Jeong Young-Hoon, Lee Seung-Wh |
|
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2012 Jul 10 (7): 1242-51. Reny J-L, Combescure C, Daali Y, Fontana P, |
|
ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: a meta-analysis.
Thrombosis research 2012 Jun 129 (6): 754-9. Luo Man, Li Jiaoxing, Xu Xiaowei, Sun Xunsha, Sheng Wen |
|
The sex-specific association of Met62Ile gene polymorphism in P-selectin glycoprotein ligand (PSGL-1) with carotid plaque presence: preliminary study.
Molecular biology reports 2012 Jun 39 (6): 6479-85. Zivkovi? Maja, Kolakovi? Ana, Radak Djordje, Din?i? Dragan, Radak Sandra, Djuri? Tamara, Stankovi? Aleksand |
|
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study.
Journal of the American College of Cardiology 2012 May 59 (22): 1928-37. Price Matthew J, Murray Sarah S, Angiolillo Dominick J, Lillie Elizabeth, Smith Erin N, Tisch Rebecca L, Schork Nicholas J, Teirstein Paul S, Topol Eric J, |
|
The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women.
Journal of thrombosis and haemostasis : JTH 2012 May 10 (5): 881-6. Said J M, Tsui R, Borg A J, Higgins J R, Moses E K, Walker S P, Monagle P T, Brennecke S |
|
The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome.
Thrombosis research 2012 Apr 129 (4): 486-91. Yonal Ipek, Hindilerden Fehmi, Hancer Veysel Sabri, Artim-Esen Bahar, Daglar Aynur, Akadam Basak, Nalcaci Meliha, Diz-Kucukkaya Reyh |
|
The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.
Seminars in thrombosis and hemostasis 2012 Mar 38 (2): 230-4. Grifoni Elisa, Marcucci Rossella, Ciuti Gabriele, Cenci Caterina, Poli Daniela, Mannini Lucia, Liotta Agatina Alessandrello, Miniati Massimo, Abbate Rosanna, Prisco Domeni |
|
No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.
Circulation. Cardiovascular interventions 2012 Feb 5 (1): 82-8, S1-2. Jaitner Juliane, Morath Tanja, Byrne Robert A, Braun Siegmund, Gebhard Daniela, Bernlochner Isabell, Schulz Stefanie, Mehilli Julinda, Schömig Albert, Koch Werner, Kastrati Adnan, Sibbing Di |
|
Prevalence of inherited thrombophilia in patients with documented stent thrombosis.
Circulation journal : official journal of the Japanese Circulation Society 2012 76 (8): 1874-9. Zavalloni Dennis, Presbitero Patrizia, Lodigiani Corrado, Mango Ruggiero, Cogliati Tommaso, Quaglia Ilaria, Corrada Elena, Mendolicchio Grazia-Loredana, Gasparini Gabriele-Luigi, Rossi Marco-Luciano, Ferrazzi Paola, Belli Guido, Pagnotta Paolo, Rota Lidia-Lucia |
|
The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.
BMC medical genetics 2012 13 (1): 6. Ohyashiki Junko H, Yoneta Masayuki, Hisatomi Hisashi, Iwabuchi Tamiko, Umezu Tomohiro, Ohyashiki Kazu |
|
The impact of prothrombin (G20210A) gene mutation on stroke in youths.
ARYA atherosclerosis 2012 8 (1): 9-11. Saadatnia Mohammad, Salehi Mansour, Amini Gilda, Seyyed Agha Miri Najm |
|
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
Alimentary pharmacology & therapeutics 2011 Nov 34 (10): 1173-84. Oussalah A, Guéant J-L, Peyrin-Biroulet |
|
The Gain-of-Function Variant Allele CYP2C19*17: A Double-Edged Sword Between Thrombosis and Bleeding in Clopidogrel-Treated Patients.
Journal of thrombosis and haemostasis : JTH 2011 Nov . Li Y, Tang HL, Hu YF, Xie HG |
|
Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.
Transplantation 2011 Sep 92 (5): 587-93. Pereboom Ilona T A, Adelmeijer Jelle, van der Steege Gerrit, van den Berg Aad P, Lisman Ton, Porte Robert |
|
[Impact of cytochrome P450 2C19 polymorphisms on outcome of cardiovascular events in clopidogrel-treated Chinese patients after percutaneous coronary intervention].
Zhonghua xin xue guan bing za zhi 2011 Jul 39 (7): 617-20. Tang Xiao-Fang, He Chen, Yuan Jin-Qing, Meng Xian-Min, Yang Yue-Jin, Qin Xue-Wen, Qiao Shu-Bin, Liu Hai-Bo, Wu Yong-Jian, Yao Min, Chen Jue, You Shi-Jie, Wu Yuan, Li Jian-Jun, Dai Jun, Chen Ji-Lin, Gao Run-Lin, Chen Zai-J |
|
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
European heart journal 2011 Jul 32 (13): 1605-13. Sibbing Dirk, Koch Werner, Massberg Steffen, Byrne Robert A, Mehilli Julinda, Schulz Stefanie, Mayer Katharina, Bernlochner Isabell, Schömig Albert, Kastrati Adn |
|
Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
Pituitary 2011 Jun 14 (2): 168-73. Gokalp Deniz, Tuzcu Alpaslan, Bahceci Mithat, Ayyildiz Orhan, Yurt Murat, Celik Yusuf, Alpagat Gulist |
|
Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents.
Heart (British Cardiac Society) 2011 Jun . Oh IY, Park KW, Kang SH, Park JJ, Na SH, Kang HJ, Koo BK, Jeong YH, Hwang JY, Kwak CH, Park Y, Hwang SJ, Ko YG, Shin DJ, Jang Y, Kim HS |
|
Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.
Blood 2011 May 117 (19): 5224-30. Campos Marco, Sun Wei, Yu Fuli, Barbalic Maja, Tang Weihong, Chambless Lloyd E, Wu Kenneth K, Ballantyne Christie, Folsom Aaron R, Boerwinkle Eric, Dong Jing-F |
|
Association between ApoE4 allele and deep venous thrombosis: a pilot study.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011 Apr 17 (2): 225-8. Katrancioglu Nurkay, Manduz Sinasi, Ozen Filiz, Yilmaz Mehmet Birhan, Atahan Erhan, Ozdemir Ozturk, Berkan Oc |
|
Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels.
Journal of thrombosis and haemostasis : JTH 2011 Jan 9 (1): 229-31. Morange P-E, Saut N, Antoni G, Emmerich J, Trégouët D |
|
Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.
PloS one 2011 6 (1): e16639. Penrod Nadia M, Poku Kwabena A, Vaughan Douglas E, Vaughn Douglas E, Asselbergs Folkert W, Brown Nancy J, Moore Jason H, Williams Scott |
|
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.
BMJ (Clinical research ed.) 2011 343 d4588. Bauer Tim, Bouman Heleen J, van Werkum Jochem W, Ford Neville F, ten Berg Jurriën M, Taubert Di |
|
[Screening for thrombophilic abnormalities in very elderly patients.]
Annales de biologie clinique 2010 Nov 68 (6): 6. Anard-Michelot H, Siguret V, Gouin-Thibault I, Siriwardana M, Gouronnec A, Pautas E |
|
Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients.
Hematology (Amsterdam, Netherlands) 2010 Aug 15 (4): 187-92. Chim C S, Sim J P, Chan C C, Kho B C, Chan J C, Wong L G, Law M, Liang R, Kwong Y |
|
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.
Journal of the American College of Cardiology 2010 Jul 56 (2): 134-43. Hulot Jean-Sébastien, Collet Jean-Philippe, Silvain Johanne, Pena Ana, Bellemain-Appaix Anne, Barthélémy Olivier, Cayla Guillaume, Beygui Farzin, Montalescot Gill |
|
A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism.
Thrombosis research 2010 Jun 125 (6): e259-64. Wells P S, Majeed H, Kassem S, Langlois N, Gin B, Clermont J, Taljaard |
|
G-protein beta3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trial.
Journal of thrombosis and haemostasis : JTH 2010 May 8 (5): 934-41. Maree A O, Vangjeli C, Jneid H, Ryan J, Cox D, Cannon C P, Shields D C, Fitzgerald D |
|
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.
Circulation 2010 Feb 121 (4): 512-8. Sibbing Dirk, Koch Werner, Gebhard Daniela, Schuster Tibor, Braun Siegmund, Stegherr Julia, Morath Tanja, Schömig Albert, von Beckerath Nicolas, Kastrati Adn |
|
Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause.
British journal of haematology 2009 Jun 146 (1): 95-103. Martínez Constantino, Antón Ana Isabel, Corral Javier, Quiroga Teresa, Panes Olga, Lozano María Luisa, González-Conejero Rocío, Teruel Raúl, Navarro-Núñez Leyre, Pereira Jaime, Mezzano Diego, Vicente Vicente, Rivera Jo |
|
The impact of genetic factors in the development of thrombosis in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15_suppl): e22227. Özkan M, Koçyigit I, Dikilitas M, Özkul Y, Sari I, Karaca H, Emirogullari F, Eser B, Er O, Unal |
|
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.
European heart journal 2009 Apr 30 (8): 916-22. Sibbing Dirk, Stegherr Julia, Latz Wolfgang, Koch Werner, Mehilli Julinda, Dörrler Katharina, Morath Tanja, Schömig Albert, Kastrati Adnan, von Beckerath Nicol |
|
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.
The American journal of cardiology 2009 Mar 103 (6): 806-11. Giusti Betti, Gori Anna Maria, Marcucci Rossella, Saracini Claudia, Sestini Ilaria, Paniccia Rita, Buonamici Piergiovanni, Antoniucci David, Abbate Rosanna, Gensini Gian Fran |
|
Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism.
Journal of vascular surgery 2008 Mar 47 (3): 566-70. Mustafa Stefan, Weltermann Ansgar, Fritsche Robert, Marsik Claudia, Wagner Oswald, Kyrle Paul A, Eichinger Sabi |
|
Lack of association between thrombosis-associated and cytokine candidate gene polymorphisms and acute rejection or vascular complications after kidney transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008 Jan 23 (1): 364-8. Alakulppi Noora S, Kyllönen Lauri E, Partanen Jukka, Salmela Kaija T, Laine Jarmo |
|
Pharmacogenetics of oral anticoagulants: a basis for dose individualization.
Clinical pharmacokinetics 2008 47 (9): 565-94. Stehle Simone, Kirchheiner Julia, Lazar Andreas, Fuhr U |
|
Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007 Oct 13 (4): 435-8. Dölek Bilgen, Eraslan Serpil, Ero?lu Sevim, Kesim Belgin Eroglu, Ulutin Turgut, Yalçiner Altan, Laleli Yahya R, Gözükirmizi Nerm |
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: